Actos – Bladder Cancer – New Lawsuits Over This Diabetes Drug
One of the latest drug lawsuits Ashcraft & Gerel has undertaken arises out of the discovery of an association between the diabetes drug Actos and bladder cancer. Actos is in the class of drugs known as glitazones, which are utilized in the treatment of diabetes. They lower blood glucose levels and increase the body’s sensitivity to insulin. The study that raised concerns about the association of Actos to bladder cancer came out of Europe and resulted in the banning of the drug in Europe and France. There has not yet been a recall in the United States, but the FDA has issued a warning. Ashcraft & Gerel’s pharmaceutical lawyers are investigating claims arising out of Actos. More information can be found by clicking here to visit our web page on Actos.
Inquiries about potential claims can be submitted by:
- Filling out and clicking the “submit” button on the “Contact Us” form on the left side of this page
- Sending us an email at inquiries@ashcraftandgerel.com
- Telephoning us at 1-800-829-7037.
Posted on September 16, 2011 at 11:44 AM
Categories: News, Product Liability
Receive new post updates: Entries (RSS)
Receive follow up comments updates: RSS 2.0
Written by Robert Samet
No comments yet. You should be kind and add one!
You must be logged in to post a comment.